Attending this event?
View analytic
Thursday, March 22 • 09:45 - 10:30
New Horizons in the diagnosis and management of interstitial lung diseases

Log in to save this to your schedule and see who's attending!

New Horizons in the diagnosis and management of interstitial lung diseases
Dr Sophie Fletcher, Consultant Respiratory Physician

avatar for Dr Sophie Fletcher

Dr Sophie Fletcher

BA BM BCh MRCP PG Cert (Med Ed), Respiratory, general and intensive care medicine
Dr Fletcher is the clinical lead for interstitial lung disease (ILD) at University Hospital Southampton. The ILD service in Southampton is a regional service in anticipation of specialist commissioning. It receives both regional and national referrals.UHS is one of the few centres in the UK able to provide the novel anti-fibrotic drugs pirfenidone and nintedanib. These medicines reduce the body's production of the excess tissue that makes breathing difficult for patients with interstitial lung disease. UHS was the first centre in the UK to provide nintedanib, and one of only 10 centres in England able to offer this option.Dr Fletcher worked with the British Lung Foundation, the biomedical research unit, the University of Southampton and Portsmouth Hospitals NHS Trust to set up a patient support group for those with ILD – WILD (Wessex ILD). You can find out more about the group by clicking... Read More →

Thursday March 22, 2018 09:45 - 10:30
Lecturer Theatre 1 University Hospital Southampton NHS Foundation Trust
Feedback form isn't open yet.

Attendees (3)